In April 2025, the U.S. Food and Drug Administration (FDA) released its Roadmap to Reducing Animal Testing in Preclinical ...

The FDA’s emerging framework represents more than a regulatory update; it is a paradigm shift toward human-relevant, science-forward drug development. By reducing reliance on animal models and ...

By fusing behavioral data, real-time analytics and generative AI, the industry is entering a new era: attention hacking at ...

Proteomics International has secured a US patent for its PromarkerEso, a breakthrough blood test enabling early detection of ...

Cofactor Genomics, a commercial-stage diagnostics company transforming precision oncology through RNA-based predictive tests, today announced strategic investments from Labcorp and Ascension Ventures.

Automakers use AI-driven predictive maintenance and computer vision control to achieve a 35-50% reduction in unscheduled ...

AUDIENCEX, the leading integrated performance marketing and technology company, announced a year of robust growth fueled by advancements in AI, predictive intelligence, and customer expansion.

Proteomics International revealed promising clinical results showing its PromarkerD blood test reliably predicts diabetic ...

Its tests aren’t perfect, but they’re better predictors of college performance than anything anyone else is using.

Adaptive test is starting to gain traction for high-performance computing and AI chips as test programs that rely on static limits and fixed test sequences reach their practical limits.

A retrospective real-world analysis presented at the 2025 ASH Annual Meeting and Exposition showed that circulating tumor DNA (ctDNA) detected at the end of treatment (EOT) was a prognostic indicator ...

In November, The Lancet published an international expert consensus review, "Contemporary, non-invasive imaging diagnosis of ...